Sagimet Biosciences (SGMT) Earnings Analysis
Sagimet Biosciences (SGMT) next reports earnings on 2026-08-12, consensus EPS -0.28 USD. Last quarter (2026-03-11) it beat with EPS -0.29 USD vs -0.43 USD est (+32.6%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E -5.22.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SGMT next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.28 USD |
| Revenue estimate | n/a |
SGMT earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-11 | -0.29 USD | -0.43 USD | +32.6% | Beat |
| 2025-11-13 | -0.4 USD | -0.41 USD | +2.4% | Beat |
| 2025-08-13 | -0.32 USD | -0.52 USD | +38.5% | Beat |
| 2025-03-12 | -0.5 USD | -0.65 USD | +23.1% | Beat |
| 2024-11-14 | -0.45 USD | -0.47 USD | +4.3% | Beat |
| 2024-08-14 | -0.25 USD | -0.34 USD | +26.5% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
SGMT valuation and analyst view
| Trailing P/E | -5.22 |
|---|---|
| Trailing EPS | -1.33638 USD |
| Price / book | 2.24 |
| Dividend yield | 0.00% |
| Market cap | 0.23B |
| Analyst consensus | Buy (6 buy / 1 hold / 0 sell) |
| Avg price target | 8 USD |
Related research pages
Frequently asked questions
When is Sagimet Biosciences (SGMT)'s next earnings date?
Sagimet Biosciences is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.28 USD.
Did SGMT beat earnings last quarter?
In its 2026-03-11 report, SGMT posted EPS of -0.29 USD versus a -0.43 USD estimate — a beat of 32.6%.
What is SGMT's earnings track record?
Over the last 6 reported quarters with consensus data, SGMT beat estimates 6 times (100%).
What is SGMT's current P/E ratio and EPS?
SGMT trades at a trailing P/E of -5.22 on trailing EPS of -1.3363757852344111 USD.
What do analysts rate SGMT?
Analyst consensus is "Buy" across 7 ratings (0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 8 USD.